BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30542119)

  • 1. Targeting TRIM3 deletion-induced tumor-associated lymphangiogenesis prohibits lymphatic metastasis in esophageal squamous cell carcinoma.
    Zhu J; Wu G; Ke Z; Cao L; Tang M; Li Z; Li Q; Zhou J; Tan Z; Song L; Li J
    Oncogene; 2019 Apr; 38(15):2736-2749. PubMed ID: 30542119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9.
    Shen Z; Zhang P; Zhang W; Luo F; Xu H; Chen S; Kang M
    Funct Integr Genomics; 2023 May; 23(2):164. PubMed ID: 37198330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma.
    Su C; Chen Z; Luo H; Su Y; Liu W; Cai L; Wang T; Lei Y; Zhong B
    J Exp Clin Cancer Res; 2011 Sep; 30(1):85. PubMed ID: 21939555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal carcinoma cell-excreted exosomal uc.189 promotes lymphatic metastasis.
    Ding Z; Yan Y; Guo YL; Wang C
    Aging (Albany NY); 2021 May; 13(10):13846-13858. PubMed ID: 34024769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma.
    Zhang L; Wang JH; Liang RX; Huang ST; Xu J; Yuan LJ; Huang L; Zhou Y; Yu XJ; Wu SY; Luo RZ; Yun JP; Jia WH; Zheng M
    Oncotarget; 2015 Oct; 6(33):34510-24. PubMed ID: 26439687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment.
    Zhang W; Hong R; Li L; Wang Y; Du P; Ou Y; Zhao Z; Liu X; Xiao W; Dong D; Wu Q; Chen J; Song Y; Zhan Q
    Mol Cancer; 2018 Aug; 17(1):125. PubMed ID: 30131072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-κB Signaling and MMP1 Expression.
    Ming XY; Zhang X; Cao TT; Zhang LY; Qi JL; Kam NW; Tang XM; Cui YZ; Zhang BZ; Li Y; Qin YR; Guan XY
    Theranostics; 2018; 8(1):185-198. PubMed ID: 29290801
    [No Abstract]   [Full Text] [Related]  

  • 10. TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-κB signaling.
    Zhang B; Zhang Z; Li L; Qin YR; Liu H; Jiang C; Zeng TT; Li MQ; Xie D; Li Y; Guan XY; Zhu YH
    Nat Commun; 2018 Apr; 9(1):1423. PubMed ID: 29650964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling.
    Huang CL; Achudhan D; Liu PI; Lin YY; Liu SC; Guo JH; Liu CL; Wu CY; Wang SW; Tang CH
    Aging (Albany NY); 2023 Jun; 15(11):4774-4793. PubMed ID: 37286356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells.
    Wang X; Li X; Li C; He C; Ren B; Deng Q; Gao W; Wang B
    Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):520-7. PubMed ID: 27125974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinoma.
    Liu L; Lin C; Liang W; Wu S; Liu A; Wu J; Zhang X; Ren P; Li M; Song L
    Gut; 2015 Jan; 64(1):26-36. PubMed ID: 24667177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factors C and D and lymphangiogenesis at the early stage of esophageal squamous cell carcinoma progression.
    Kumagai Y; Tachikawa T; Higashi M; Sobajima J; Takahashi A; Amano K; Fukuchi M; Ishibashi K; Mochiki E; Yakabi K; Tamaru J; Ishida H
    Dis Esophagus; 2018 Aug; 31(8):. PubMed ID: 29800478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA.
    Tian F; Zang WD; Hou WH; Liu HT; Xue LX
    Acta Biochim Biophys Sin (Shanghai); 2006 May; 38(5):318-26. PubMed ID: 16680372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling.
    Lu Z; Chen Z; Li Y; Wang J; Zhang Z; Che Y; Huang J; Sun S; Mao S; Lei Y; Gao Y; He J
    J Mol Med (Berl); 2018 Apr; 96(3-4):301-313. PubMed ID: 29379981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cIAP2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the NF-κB pathway.
    Jiang X; Li C; Lin B; Hong H; Jiang L; Zhu S; Wang X; Tang N; Li X; She F; Chen Y
    Cancer Sci; 2017 Jun; 108(6):1144-1156. PubMed ID: 28295868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diacylglycerol kinase α (DGKα)/Akt/NF-κB feedforward loop promotes esophageal squamous cell carcinoma (ESCC) progression via FAK-dependent and FAK-independent manner.
    Chen J; Zhang W; Wang Y; Zhao D; Wu M; Fan J; Li J; Gong Y; Dan N; Yang D; Liu R; Zhan Q
    Oncogene; 2019 Apr; 38(14):2533-2550. PubMed ID: 30532074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAB3 promotes human esophageal squamous cell carcinoma proliferation and invasion via the NF‑κB pathway.
    Zhao J; Gai L; Gao Y; Xia W; Shen D; Lin Q; Mao W; Wang F; Liu P; Chen J
    Oncol Rep; 2018 Nov; 40(5):2876-2885. PubMed ID: 30226617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
    Shin WS; Hong Y; Lee HW; Lee ST
    Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.